Detection of a soluble form of the leukocyte surface antigen CD48 in plasma and its elevation in patients with lymphoid leukemias and arthritis

Journal of Clinical Immunology

Volumn 17, Issue 6, 1997, Pages 502-509

  Smith, Glenn M ^a   Biggs, James ^a   Norris, Belinda ^a   Anderson Stewart, Peter ^a   Ward, Robyn ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

Arthritis; CD48; Leukocyte surface antigen; Lymphoid leukemias; Plasma; Soluble form

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; LEUKOCYTE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTHRITIS; ARTICLE; CARCINOGENESIS; CHO CELL; ENZYME ACTIVITY; LYMPHATIC LEUKEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAJI CELL; TISSUE CULTURE;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, SURFACE; ARTHRITIS; CELL LINE; FEMALE; FLOW CYTOMETRY; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOASSAY; LEUKEMIA, LYMPHOCYTIC; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LEUKOCYTES; LEUKOCYTES, MONONUCLEAR; LYMPHOMA, NON-HODGKIN; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; MICE, NUDE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; SENSITIVITY AND SPECIFICITY;

EID: 0031442143     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1027327912204     Document Type: Article

References (30)

1. Low M, Saltiel A: Structural and functional roles of glycosyl-phosphatidylinositol in membranes. Science 239:268, 1988
2. Slefanova I, Horejsi V, Ansotegui I, Knapp W, Stockinger H: GPI-Anchored cell-surface molecules complexed to protein tyrosine kinases. Science 254:1016, 1991
3. Solomon KR, Rudd CE, Finberg RW: The association between GPI-anchored proteins and heterotrimeric G protein subunits in lymphocytes. Proc Natl Acad Sci USA 93:6053-6058, 1996
4. Kooyman D, Byrne G, McClennan S, Nielsen D, Tone M, Waldmann H, Coffman T, McCurry K, Platt J, Logan J: In vivo transfer of GPI-linked complement restriction factors from erythrocytes to the endothelium. Science 269:89, 1995
5. Gold P, Shuster J, Freedman S: Carcinoembryonic antigen (CEA) in clinical medicine. Cancer 42:1399, 1978
6. Fleit H, Kobasiuk C, Daly C, Furie R, Levy P, Webster R: A soluble form of FcγRIII is present in human serum and other body fluids and is elevated at sites of inflammation. Blood 79:2721, 1992
7. Bazil V, Strominger J: Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J Immunol 147:1567, 1991
8. Mizukami I, Faulkner N, Gyetko M, Sitrin R, Todd R: Enzyme-linked immunoabsorbent assay detection of a soluble form of urokinase plasminogen activator receptor in vivo. Blood 86:203, 1995
9. Caras I, Davitz M, Rhee L, Weddell G, Martin D, Nussenzweig V: Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins. Nature 325:545, 1987
10. Bazil V: Physiological enzymatic cleavage of leukocyte membrane molecules. Immunol Today 16:135, 1995
11. Wang J, Tang R, Chiang J: Value of Carcinoembryonic antigen in the management of colorectal cancer. Dis Colon Rectum 37:272, 1994
12. Henniker A, Bradstock K, Grimsley P, Atkinson M: A novel non-lineage antigen on human leucocytes: Characterization with two CD-48 monoclonal antibodies. Dis Mark 8:179, 1990
13. Vaughan H, Thompson C, Sparrow R, McKenzie I: HU LY-M3 - A human leukocyte antigen. Transplantation 36:446, 1983
14. Hadam M: Cluster report: CD48. Leucocyte Typing IV:661, 1989
15. Thorley-Lawson D, Ianelli C, Klaman L, Staunton D, Yokoyama S: Function of CD48 and its regulation by Epstein-Barr virus. Biochem Soc Trans 21:976, 1993
16. Kato K, Koyanagi M, Okada H, Takanashi T, Wah Wong Y, Williams A, Okumura K, Yagita H: CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation. J Exp Med 176:1241, 1992
17. Arulanandam A, Moingeon P, Concino M, Recny M, Kato K, Yagita H, Koyasu S, Reinherz E: A soluble multimeric recombinant CD2 protein identifies CD48 as a low affinity ligand for human CD2: Divergence of CD2 ligands during the evolution of humans and mice. J Exp Med 177:1439, 1993
18. Anton van der Merwe P, Barclay A, Mason D, Davies E, Morgan B, Tone M, Krishnam A, Ianelli C, Davis S: Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with a very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59. Biochemistry 33:10149, 1994
19. Korinek V, Stefanova I, Angelisova P, Hilgert I, Horejsi V: The human leucocyte antigen CD48 (MEM-102) is closely related to the activation marker BLAST-1. Immunogenetics 33:108, 1991
20. Vaughan H, Henning M, Purcell D, McKenzie I, Sandrin M: The isolation of cDNA clones for CD48. Immunogenetics 33:113, 1991
21. Staunton D, Thorley-Lawson D: Molecular cloning of the lymphocyte activation marker BLAST-1. J Exp Med 169:1087, 1989
22. Fisher R, Thorley-Lawson D: Characterization of the Epstein-Barr virus-inducible gene encoding the human leucocyte adhesion and activation antigen BLAST-1 (CD48). Mol Cell Biol 11:1614, 1991
23. Calender A, Billaud M, Aubry J-P, Banchereau J, Vuillaume M, Lenoir G: Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells. Proc Natl Acad Sci USA 84:8060, 1987
24. Thorley-Lawson D, Schooley R, Bhan A, Nadler L: Epstein-Barr virus superinduces a new human B cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts. Cell 30:415, 1982
25. Yokoyama S, Staunton D, Fisher R, Amiot M, Fortin J, Thorley-Lawson D: Expression of the BLAST-1 activation/adhesion molecule and its identification as CD48. J Immunol 146:2192, 1991
26. Metz C, Brunner G, Choi-Muira N, Nguyen H, Gabrilove J, Caras I, Altszuler N, Rfikin D, Wilson E, Davitz M: Release of GPI-anchored membrane proteins by a cell-associated GPI-specific phospholipase D. EMBO J 13:1741, 1994
27. Duke O, Panavi G, Janossy G, Poulter L: An immunohistochemical analysis of lymphocyte subpopulation and their microenvironment in the synovial membrane of patients with rheumatoid arthritis using monoclonal antibodies. Clin Exp Immunol 49:22, 1982
28. Harlow E, Lane D: Antibodies. A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1988
29. Metz C, Brunner G, Choi-Muira N, Nguyen H, Gabrilove J, Caras I, Altszuler N, Rifkin D, Wilson E, Davitz M: Release of GPI-anchored membrane proteins by a cell-associated GPI-specific phospholipase D. EMBO J 13:1741, 1994
30. Rai KR, Sawitsky A, Cronkite EP, Chanana A, Levy RN, Pasternak BS: Clinical staging of chronic lymophcytic leukaemia. Blood 46:219-234, 1975